What is the main business of PTC Therapeutics Poland?

The main business activity of PTC Therapeutics Poland focuses on public relations and communication activities.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on June 8, 2022.

Where is the headquarters located?

The headquarters is located at: ul. Kaleńska 5, 04-367 Warszawa.

What is the share capital?

The share capital of the company is PLN 450,000 (approx. $121,556).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

How much revenue was generated?

The company reported a revenue of $1,569,906 in 2025, which is an increase of 6.3% compared to 2024.

Is the company profitable?

Yes, the company recorded a net profit of $176,103 in 2025, meaning the company increased its profit by 14.3%.

What is the main operating cost?

The largest operating cost category falls under employee remuneration. This category amounted to $1,029,379 in 2025, representing 77% of all operating expenses.

PTC Therapeutics Polandsp. z o.o.

Public relations and communication activities

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2022-06-08

Share capital

450,000.00 PLN

Activity description

PTC Therapeutics Poland develops and commercializes medicines for children and adults with serious diseases and high unmet medical needs. Its focus includes phenylketonuria, AADC deficiency, Duchenne muscular dystrophy and Friedreich’s ataxia, and it conducts clinical trials.

Registered address

ul. Kaleńska 5, 04-367 Warszawa, Poland

Website

ptcbio.com

Social media

Electronic delivery address

AE:PL-90542-80033-IIHWF-10

Financials

Revenue history (in k)

Filing timeliness

1 of 4 financial statements was filed late (for 2022, 80 days late).

202525/05/2026
202405/06/2025
202306/05/2024
202203/10/2023

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 1.57mMedianUSD 97.47kAverageUSD 604.54k

Net profit

This companyUSD 176.10kMedianUSD 1.96kAverageUSD 22.07k

Operating costs

This companyUSD 1.34mMedianUSD 88.90kAverageUSD 554.48k

Assets

This companyUSD 1.13mMedianUSD 58.89kAverageUSD 409.17k

Industry

Offer

Medicines for rare diseases
Patient therapies
Clinical trials

Website technology

Website

WordPress

Analytics and marketing

Google Tag Manager

Authorized Representatives

Bernt Roger Johansson – Management Board Member

Melissa Jane Kenny – Management Board Member

Manner of representation

If the management board is a one-person management board, the member of the management board represents the company independently. In the case of a multi-member management board, each member of the management board is authorised to represent the company independently.

Ownership

Owner	Shares	Share value	Stake
Ptc Therapeutics International Limited	9,000	$121,555.92	100%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2022-09-20.

HSBC Continental Europe Oddział w Polsce
23 1280 0003 0000 0031 9009 7031
HSBC Continental Europe Oddział w Polsce
02 1280 0003 0000 0031 9009 7021

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Adamed Technologysp. z o.o.	$8,360,772.47	adamedtechnology.com
LEO Pharmasp. z o.o.	$5,458,511.74	leo-pharma.pl
OD SercaS.A.	$1,697,427.14	aptekaodserca.pl
PCCsp. z o.o.	$232,757.69	pcc1.pl

Change history

Date	Event
2023-01-16	Address change (Plac Konesera 12, 03-736, Warszawa → Ul. Kaleńska 5, 04-367, Warszawa)
2022-06-08	Entered in the register

FAQ

Last updated: 2026-10-07